Tamoxifen Citrate

Product NDC
71335-0237
11-digit product format
713350237
Labeler code
71335
Product ID
71335-0237_1bb81dd5-8d4e-4d6d-b030-a8ff2a3d4f55
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tamoxifen Citrate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075797
Marketing category
ANDA
Marketing start
2016-08-03
Marketing end
0000-00-00
Substance
TAMOXIFEN CITRATE
Active strength
20 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-0237-17133502370130 TABLET, FILM COATED in 1 BOTTLE (71335-0237-1) 2021-12-270000-00-00NoNoCurrent
71335-0237-27133502370260 TABLET, FILM COATED in 1 BOTTLE (71335-0237-2) 2021-12-270000-00-00NoNoCurrent
71335-0237-37133502370390 TABLET, FILM COATED in 1 BOTTLE (71335-0237-3) 2021-12-270000-00-00NoNoCurrent
71335-0237-47133502370428 TABLET, FILM COATED in 1 BOTTLE (71335-0237-4) 2021-12-270000-00-00NoNoCurrent
71335-0237-57133502370558 TABLET, FILM COATED in 1 BOTTLE (71335-0237-5) 2021-12-270000-00-00NoNoCurrent
71335-0237-67133502370652 TABLET, FILM COATED in 1 BOTTLE (71335-0237-6) 2021-12-270000-00-00NoNoCurrent